197 related articles for article (PubMed ID: 33599318)
21. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
Eden CG; Arora A; Rouse P
BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
[TBL] [Abstract][Full Text] [Related]
22. The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy.
Sebben M; Tafuri A; Shakir A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Tiso L; De Michele M; Panunzio A; Cerrato C; Brunelli M; Migliorini F; Novella G; De Marco V; Siracusano S; Artibani W; Porcaro AB
World J Urol; 2020 Nov; 38(11):2799-2809. PubMed ID: 31980875
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
[TBL] [Abstract][Full Text] [Related]
24. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
[TBL] [Abstract][Full Text] [Related]
25. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
26. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
27. Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer.
Porcaro AB; de Luyk N; Corsi P; Sebben M; Tafuri A; Tamanini I; Processali T; Cerruto MA; Migliorini F; Brunelli M; Siracusano S; Artibani W
Tumori; 2017 May; 103(3):299-306. PubMed ID: 27716882
[TBL] [Abstract][Full Text] [Related]
28. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
[TBL] [Abstract][Full Text] [Related]
29. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Matsumoto T; Hatakeyama S; Ookubo T; Mitsuzuka K; Narita S; Inoue T; Yamashita S; Narita T; Koie T; Kawamura S; Tochigi T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
Med Oncol; 2017 Oct; 34(12):190. PubMed ID: 29090390
[TBL] [Abstract][Full Text] [Related]
31. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
[TBL] [Abstract][Full Text] [Related]
32. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
33. Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy.
Gandaglia G; Suardi N; Gallina A; Abdollah F; Capitanio U; Salonia A; Colombo R; Bianchi M; Chun FK; Hansen J; Rigatti P; Montorsi F; Briganti A
J Sex Med; 2012 Aug; 9(8):2187-94. PubMed ID: 22738395
[TBL] [Abstract][Full Text] [Related]
34. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution.
Tomisaki I; Ikuta H; Higashijima K; Onishi R; Minato A; Fujimoto N
Cancer Invest; 2019; 37(10):524-530. PubMed ID: 31597501
[TBL] [Abstract][Full Text] [Related]
35. Four-point Peritoneal Flap Fixation in Preventing Lymphocele Formation Following Radical Prostatectomy.
Stolzenburg JU; Arthanareeswaran VKA; Dietel A; Franz T; Liatsikos E; Kyriazis I; Ganzer R; Yaney K; Do HM
Eur Urol Oncol; 2018 Oct; 1(5):443-448. PubMed ID: 31158086
[TBL] [Abstract][Full Text] [Related]
36. Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.
Bianchi L; Gandaglia G; Fossati N; Suardi N; Moschini M; Cucchiara V; Bianchi M; Damiano R; Schiavina R; Shariat SF; Montorsi F; Briganti A
Urologia; 2017 Feb; 84(1):9-19. PubMed ID: 26689534
[TBL] [Abstract][Full Text] [Related]
37. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
[TBL] [Abstract][Full Text] [Related]
38. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
39. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
[TBL] [Abstract][Full Text] [Related]
40. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
